Impact of Biological Factors on Dental Implant

Sponsor
Al-Mustansiriyah University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06037070
Collaborator
(none)
10
1
2
10.3
1

Study Details

Study Description

Brief Summary

The goal of this randomized controlled trial is to compare the response of different bone densities to treatment with Platelet Rich Fibrin (PRF) in patients who need treatment with dental implant.

The main questions it aims to answer are:
  • To investigate if bone reaction to PRF differ with different bone densities.

  • To study the effect of PRF on dental implant healing and to assess its effectiveness in accelerating osseointegration.

Participants who need treatment with dental implant will be planned to include in this study and will be asked if they are willing to participate in this study voluntarily.

All the participants will be given an information sheet and a consent form which provides simple description about the present study and its importance to insure voluntary participation. The patients will be aware that they are completely free to withdraw from the research any time during the research time.

Platelet Rich Fibrin will be injected inside the hole that prepared to place dental implant in. Bone density will be evaluated, degree of osseointegration will be monitored.

Condition or Disease Intervention/Treatment Phase
  • Biological: Platelet Rich Fibrin
N/A

Detailed Description

Materials and methods:

Two implants will be implanted at the same time, one will have PRF that will be injected inside the hole that prepared to place dental implant in [PRF is obtained from a blood sample is taken from the patient at the time of surgery in 10-mL tubes, the blood-containing tube is placed in a centrifuge at specially controlled rotations, temperature and time]. The other implant will not receive any treatment (the control one).

Evaluation of the results

  • Evaluation of bone density in implant site will be determined using CBCT [ the same CBCT that have been used for planning dental implant treatment].

***[In dental implant treatment it is mandatory to perform CBCT for each patient, to ensure the accuracy of dental implant size and position, and to ensure there will be no damage to any vital structure during surgery (e.g. inferior dental nerve, maxillary sinus, …etc)].

  • Evaluation of the degree of osseointegration will be performed using Osstell devise. [Osstell is a tool uses Resonance Frequency Analysis (RFA) that measures the frequency with which a device vibrates]. Measurement will be conducted at implant placement for a baseline reading and after 2weeks, 4weeks, 8 weeks, 10 weeks, 12 weeks.

  • Evaluate pain by visual analogue score (VAS).

  • Estimate of the complete blood picture, vit D, Ca and K will obtained from laboratory results.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Split-mouth trialsSplit-mouth trials
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Impact of Biological Factors on Dental Implant Osseointegration
Anticipated Study Start Date :
Sep 20, 2023
Anticipated Primary Completion Date :
May 30, 2024
Anticipated Study Completion Date :
Jul 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: group with PRF

PRF placed inside the hole that prepared to place dental implant

Biological: Platelet Rich Fibrin
PRF will be injected inside the hole that prepared to place dental implant

No Intervention: control group

with out and additive

Outcome Measures

Primary Outcome Measures

  1. osseointegration [Immediately after surgery, after two weeks, 4 weeks, 6 weeks, 8weeks, 10 weeks, and 12 weeks]

    Evaluation of the changes in the degree of osseointegration will be performed using Osstell devise.

  2. Bone density [before surgery, with the treatment plan preparation]

    Determined using CBCT

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes

Inclusion criteria

  • Non- smoker.

  • No medical history of any systemic diseases that affect the bone metabolism.

  • Did not receive any systemic drugs.

  • Has edentulous area that needs at least two successive implants.

The exclusion criteria were as follows:
  • Systemic disease or medication compromising bone and soft tissue healing.

  • Pathology in the edentulous region.

  • Bruxism.

  • Disease of the oral mucosa.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kadhimiya Teaching HospitalKadhimiya Educational Hospital Baghdad Alkadhmiya City Iraq 60 St

Sponsors and Collaborators

  • Al-Mustansiriyah University

Investigators

  • Principal Investigator: Afya SD Al-radha, Ph. D, College of Dentistry / Mustansiriyah University, P.O. Box: 14022,Baghdad, Iraq

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Afya Sahib Diab Al-radha, Assistant Professor, Al-Mustansiriyah University
ClinicalTrials.gov Identifier:
NCT06037070
Other Study ID Numbers:
  • MUOSU-202104
First Posted:
Sep 14, 2023
Last Update Posted:
Sep 14, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Afya Sahib Diab Al-radha, Assistant Professor, Al-Mustansiriyah University

Study Results

No Results Posted as of Sep 14, 2023